UAE pharmaceutical market: where we are today

13 January 2023

The United Arab Emirates (UAE) ranks first regionally in attracting multinational pharmaceutical companies, writes The Pharma Letter's local correspondent.

In 2022, UAE was ranked first among all countries in the Middle East and North Africa (MENA) region in attracting multinational companies (MNCs) in the field of the pharmaceutical industry, with a total number of 92 marketing offices, employing more than 3,000 employees, along with a foreign direct investment value of around $817 million.

These offices support cooperation with health regulatory authorities to provide new medicines in the whole country immediately after approval in their reference countries. They also contribute to the national economy development through the inflow of foreign direct investment (FDI), which induces changes in the country's industrial structure and promotes economic development.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK